Accelerating stakeholder collaboration to enhance the clinical trials environment in the EU

22 marzo 2024 – The Accelerating Clinical Trials in the EU (ACT EU) initiative has established a multi-stakeholder platform (MSP) aimed at improving the environment for clinical trials across the European Union (EU). ACT EU is a collaboration between the European Medicines Agency (EMA), the Heads of Medicines Agencies (HMA), and the European Commission (EC), which seeks to transform how clinical trials are initiated, designed, and run.

For more information, see here.